Welcome! Login | Register
 

Sharks Edge Albany, 2-1 in OT—Sharks Edge Alban 2-1 in Overtime

NEW: Belichick Discusses Patriots Internal Investigation Into Deflate Gate—Bill Belichick addressed the New England media in…

Gronkowski Is That Good—Seahawks cornerback Jeremy Lane said he did not…

Fit For Life: The Rule of Expectation—When I went to write this week’s column,…

Holy Cross Beats Navy 76-65, Wins 2nd Straight—Holy Cross defeats Navy 76-65

Leonard Moorehead, The Urban Gardener: Snow is Good for Gardens—Polar vortex, wind chill factors, deep layers of…

Holy Cross - Navy Game Moved to 12:05 p.m. Due to Snow—Holy Cross game against Navy moved to 12:05…

Patriots Chairman and CEO Robert Kraft Statement—Patriots Chairman and CEO Robert Kraft releases statement

NFL Releases Statement on Deflate Gate—NFL Releases Statement on Deflate Gate

Sharks Winning Streak Ends, Fall 3-2 to Devils—Sharks winning streak snapped, fall to Albany 3-2

 
 

AG Announces $68.5 Million Settlement with AstraZeneca

Friday, March 11, 2011

 

Attorney General Peter Kilmartin announced today that a $68.5 million dollar settlement has been reached with AstraZeneca Pharmaceuticals.

This settlement, which is the largest ever multi-state consumer protection-based pharmaceutical settlement, is expected to bring $908,838 to the state.

The settlement stems from a complaint alleging that AstraZeneca used deceptive practices to market the antipsychotic drug Seroquel for off-label uses, according to the Attorney General. The company was accused of withholding information on the drug’s dangerous potential side effects, in addition to the negative results of scientific study done that tested the safety of the drug.

“This settlement shows the commitment of this office to protect consumers from deceptive marketing and advertising practices by big pharmaceutical companies,” Kilmartin said.

Company promises changes

AstraZeneca has promised to alter the way that it markets Seroquel, eliminating the misleading practices in question. Along with the $68.5 million payment, under the settlement AstraZeneca must comply with provisions addressing numerous concerns that an extensive 3-year investigation yielded. For example, AstraZeneca must have policies in place to ensure that sales personnel do not promote to health care providers who are unlikely to prescribe Seroquel for an FDA-approved use.

Other states participating in the investigation and settlement were: Florida, Illinois, Arizona, California, Colorado, Connecticut, Delaware, Hawaii, Idaho, Iowa, Kansas, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Nebraska, Nevada, New Hampshire, New Jersey, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Dakota, Tennessee, Texas, Vermont, Washington, West Virginia and Wisconsin.
 

 

Enjoy this post? Share it with others.